Skip to content

Role of phosphatidylinositol 3 kinase in metastasis and grading of luminal breast cancer subtypes

Role of phosphatidylinositol 3 kinase in metastasis and grading of luminal breast cancer subtypes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240615001
Enrollment
100
Registered
2024-06-15
Start date
2022-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with the luminal subtype breast cancer metastasis breast cancer phosphatidylinositol 3-kinase luminal subtype

Interventions

PI3K expression was considered overexpressed if staining expression (2+ to 3+) was found in more than 25% of tumor cells in cancer specimens. ,PI3K expression was considered not overexpressed if stain
Basic Science,Basic Science
PI3K expression positive,PI3K expression negative

Sponsors

Self funding
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 65 Years

Inclusion criteria

Inclusion criteria: The Inclusion Criteria included female breast cancer patients aged 17 to 65 years with the luminal subtype, a normal BMI, metastatic or non-metastatic disease, and willingness to participate in the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria included luminal subtype breast cancer patients with positive HER2/Neu immunohistochemistry examinations, the presence of other malignancies (colorectal cancer, liver cancer, lung cancer, brain cancer), or tissue samples not suitable for immunohistochemistry examination (discohesion, denaturation).

Design outcomes

Primary

MeasureTime frame
PI3K expression After patients underwent surgery immunohistochemistry examination

Secondary

MeasureTime frame
Characteristic data, histopathological grading and metastasis (presence or absence). When patien admitted to our hospital age, sex, histopathological grading (I, II, or III) and metastasis (presence or absence).

Countries

Indonesia

Contacts

Public ContactYusfitaria Alvina

Universitas Hasanuddin

yusfitaria.alvina@gmail.com062411585984

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026